In non-tumor diseases, studies have shown that TNF-induced palmitoylation of RIPK1 (mediated by DHHC5 and dependent on its K63 ubiquitination) is a key mechanism that activates RIPK1 kinase activity and bypasses the cell death checkpoint, thereby inducing downstream apoptosis/necroptosis. Here, RIPK1 is linked to neoplasm.